Harbor Capital Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Harbor Capital Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,466	Closed	-$127K	–	500
2023 Q2	$127K	Buy	10,466 +957	+10%	+$10.9K	0.03%	409
2023 Q1	$121K	Sell	9,509 -548	-5%	-$6.07K	0.03%	233
2022 Q4	$63.6K	Sell	10,057 -215	-2%	-$3.81K	0.06%	156
2022 Q3	$232K	Buy	10,272 +315	+3%	+$8.62K	0.21%	80
2022 Q2	$191K	Buy	9,957 +482	+5%	+$11.9K	0.15%	82
2022 Q1	$440K	Sell	9,475 -1,883	-17%	-$103K	0.21%	81
2021 Q4	$805K	Buy	+11,358	New	+$1.14M	0.29%	82

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return